HYBRID Coating 10-Q 19 Nov 13 2013 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2013	Nov. 12, 2013
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-13	'
Trading Symbol	'hcti	'
Entity Registrant Name	'HYBRID Coating Technologies Inc.	'
Entity Central Index Key	'0001445235	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	9,084,283
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Well Known Seasoned Issuer	'No	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q3	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012
Current assets	'	'
Prepaid rent-related party	$11,250	$0
Total Current Assets	11,250	0
Intangible asset, net of accumulated amortization	481,330	626,963
TOTAL ASSETS	492,580	626,963
Current liabilities	'	'
Bank overdraft	3,810	22,104
Accounts payable and accrued liabilities	496,189	435,245
Accounts payable and accrued liabilities-related parties	439,987	554,633
Stock payable	15,000	15,000
Senior Secured Convertible Debentures	200,000	200,000
Loans payable net of unamortized discount of $11,430 and $14,638, respectively	966,070	694,362
Loans payable -shareholders net of unamortized discount of $11,710 and $25,195, respectively	1,212,768	1,062,521
Note payable - related party	703,351	800,481
Total current liabilities	4,037,175	3,784,346
Convertible Debentures, net of unamortized discount of $160,313 and $325,136, respectively	1,160,187	995,364
Derivative liability	119,279	166,721
Total liabilities	5,316,641	4,946,431
Commitments and contingencies	0	0
STOCKHOLDERS' DEFICIT	'	'
Common stock, $0.001 par value, 75,000,000 shares authorized, 8,884,283 shares and 6,503,568 shares issued and outstanding, respectively	8,884	6,504
Additional paid-in capital	9,311,006	6,651,428
Deficit accumulated during development stage	-14,143,951	-10,977,400
Total stockholders' deficit	-4,824,061	-4,319,468
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$492,580	$626,963

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Loans payable- net of unamortized discount	$11,430	$14,638
Loans payable -shareholders net of unamortized discounts and premiums	11,710	25,195
Convertible Debentures, net of unamortized discount	$160,313	$325,136
Common Stock, Par Value Per Share	$0.00	$0.00
Common Stock, Shares Authorized	75,000,000	75,000,000
Common Stock, Shares, Issued	8,884,283	6,503,568
Common Stock, Shares, Outstanding	8,884,283	6,503,568

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended		39 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
Revenues	$48,483	$4,322	$56,631	$13,705	$128,143
Cost of sales	22,312	2,200	25,979	4,300	57,679
Gross margin	26,171	2,122	30,652	9,405	70,464
Operating expenses	'	'	'	'	'
General and administrative	591,851	437,394	1,903,852	1,490,629	9,406,332
Impairment of intangible asset	0	0	0	0	631,917
Amortization of intangible asset	36,390	54,660	145,633	163,980	636,753
Total operating expenses	628,241	492,054	2,049,485	1,654,609	10,675,002
Loss from operations	-602,070	-489,932	-2,018,833	-1,645,204	-10,604,538
Other income (expenses):	'	'	'	'	'
Warrant modification expense	0	0	-241,697	0	-241,697
Loss on extinguishment of debt	-22,000	0	-315,791	0	-418,258
Change in fair value of derivative liability	11,537	51,656	47,442	394,850	485,690
Interest expense	-208,304	-124,184	-637,672	-489,245	-3,365,148
Net loss	($820,837)	($562,460)	($3,166,551)	($1,739,599)	($14,143,951)
Basic and diluted net loss per share	($0.09)	($0.09)	($0.41)	($0.28)	'
Basic and diluted weighted average shares	8,786,457	6,492,318	7,785,062	6,231,458	'

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	9 Months Ended		39 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES	'	'	'
Net loss	($3,166,551)	($1,739,599)	($14,143,951)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:	'	'	'
Stock-based compensation	1,062,703	408,753	5,574,254
Warrant modification expense	241,697	0	241,697
Impairment of samples and supplies	0	0	10,136
Interest paid through issuance of shares	8,828	213,100	221,928
Amortization of intangible asset	145,633	163,980	636,753
Interest expense from revaluation of SSCD warrants	0	0	1,180,886
Interest expense on beneficial conversion feature related to SSCD warrants	0	0	126,607
Loss on extinguishment of debt	315,791	0	418,258
Loss on impairment of intangible assets	0	0	631,917
Change in fair value of derivative liability	-47,442	-394,850	-485,690
Interest imputed from notes payable -related party	101,776	0	271,228
Incentive and interest paid on prepayment of debt	0	0	25,833
Amortization of debt discounts	240,538	197,310	955,044
Foreign currency	-1,572	0	0
Change in operating assets and liabilities	'	'	'
Samples and supplies	0	37,836	-10,136
Accounts payable and accrued liabilities	220,507	304,503	669,919
Accounts payable and accrued liabilities related parties	476,604	229,445	1,031,237
Net cash used in operating activities	-401,488	-579,522	-2,644,080
CASH FLOWS FROM INVESTING ACTIVITIES	'	'	'
Proceeds from sale of intangible asset	0	0	150,000
Net cash provided in investing activities	0	0	150,000
CASH FLOWS FROM FINANCING ACTIVITIES	'	'	'
Bank overdraft borrowing (repayment)	0	-36,606	22,104
Proceeds from issuance of Convertible Debentures	0	119,500	970,500
Proceeds from Senior Secured Convertible Debentures	0	0	400,000
Proceeds from exercise of warrants	0	0	25,000
Proceeds from loans payable-shareholders	562,648	547,094	2,294,544
Repayments from loans payable - shareholders	-335,630	-253,716	-1,099,822
Proceeds from loans payable	260,000	411,500	1,018,375
Repayments of note payable - related party	-85,530	-208,250	-1,135,049
Net cash provided by financing activities	401,488	579,522	2,495,652
INCREASE (DECREASE) IN CASH	0	0	0
CASH, BEGINNING	0	0	0
CASH, ENDING	0	0	0
Supplemental disclosure of cash flow information	'	'	'
Interest paid	85,725	0	175,105
Income taxes	0	0	0
Non cash financing transactions:	'	'	'
Reclassification of bank overdrafts to payables	16,266	0	16,266
Acquisition of intangible asset through issuance of note payable	0	0	1,900,000
Discount arising from warrants attached to issuance of SSCD	0	0	273,393
Discount arising from loans payable - shareholders	9,148	0	101,223
Transfer of loans and SSCD to convertible debentures	0	0	310,000
Reclassification of accrued interest to SSCD	0	0	14,167
Shares issued for premium on shareholder loans	0	28,000	64,000
Discount arising from loans payable	0	0	16,868
Discounts arising from loans payable	23,705	0	23,705
Fair value of derivative convertible debentures	0	46,721	604,969
Cashless exercise of warrants	70	0	275
Reclassification of note payable to accounts payable	11,600	0	11,600
Warrants issued to pay shareholder loan	125,022	0	125,022
Warrants issued for settlement of rent liability and prepaid rent	116,250	0	116,250
Common stock issued and payable for interest accrual	180,957	0	180,957
Common stock issued for settlement of accounts payable related party	$497,500	$0	$497,500

NATURE_OF_BUSINESS_AND_BASIS_O

NATURE OF BUSINESS AND BASIS OF PRESENTATION	9 Months Ended
	Sep. 30, 2013
NATURE OF BUSINESS AND BASIS OF PRESENTATION [Text Block]	'
	NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION
	Hybrid Coating Technologies Inc. (the “Company”, “HCT”) formerly EPOD Solar Inc., was incorporated in the State of Nevada on July 8, 2010, and is in the development stage as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 915, “Development Stage Entities”.
	The Company manufactures and sells under license, alternative non-toxic (isocyanate-free) polyurethane, Green Polyurethane™, including coatings and raw binder ingredients (Green Polyurethane® Monolithic Floor Coating and Green Polyurethane™ Binder). See Note 2 for additional information on the related party licensor.
	The accompanying consolidated financial statements, which should be read in conjunction with the financial statements and footnotes of Hybrid Coating Technologies Inc. included in Form 10-K filed on April 16, 2013, with the Securities and Exchange Commission, are unaudited, and have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the period ended September 30, 2013 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2013.
	Going Concern
	The Company remains highly dependent upon funding from non-operational sources. The Company’s consolidated financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred net losses of approximately $14,144,000 since inception, and has a working capital deficit of approximately $4,026,000 as of September 30, 2013. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of these uncertainties.
	There are no assurances that the Company will be able to either (1) achieve a level of revenues adequate to generate sufficient cash flow from operations; or (2) obtain additional financing through either private placement, public offerings and/or bank financing necessary to support the Company's working capital requirements. If adequate working capital is not available the Company may be required to curtail or cease its operations.
	The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty .

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Text Block]	'
	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Basis of Presentation - The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars. The Company’s fiscal year end is December 31.
	Principles of consolidation - The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Nanotech Industries International Inc., (“Nanotech”). All significant inter-company balances and transactions have been eliminated in the consolidated financial statements.
	Development Stage – The Company complies with Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 915 “Development Stage Entities” in its characterization of the Company as a development stage enterprise.
	Use of estimates – The preparation of financial statements in conformity with generally accepted accounting principles requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates.
	Revenue recognition – Revenue is recognized when persuasive evidence of an arrangement exists, goods are delivered, sales price is determinable, and collection is reasonably assured.
	Stock-Based Compensation – For stock and stock options awarded in return for services rendered, the expense is measured at the grant-date fair value of the award and recognized as compensation expense on a straight-line basis over the service period, which is the vesting period. The Company estimates forfeitures that it expects will occur and records expense based upon the number of awards expected to vest.
	Fair Value Measurements - Fair value is the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value measurements are classified and disclosed in one of the following categories:
	Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. The Company considers active markets as those in which transactions for the assets or liabilities occur in sufficient frequency and volume to provide pricing information on an ongoing basis.
	Level 2: Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability. This category includes those derivative instruments that the Company values using observable market data. Substantially all of these inputs are observable in the marketplace throughout the term of the derivative instruments, can be derived from observable data, or supported by observable levels at which transactions are executed in the marketplace.
	Level 3: Measured based on prices or valuation models that require inputs that are both significant to the fair value measurement and less observable from objective sources (i.e. supported by little or no market activity). The Company’s valuation models are primarily industry standard models. Level 3 instruments include derivative warrant instruments. The Company does not have sufficient corroborating evidence to support classifying these assets and liabilities as Level 1 or Level 2.
	Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels. The estimated fair value of the derivative warrant instruments was calculated using a modified lattice valuation model.
	Earnings (Loss) per Share - Basic net loss per share amounts are computed by dividing the net loss by the weighted average number of common shares outstanding over the reporting period. In periods in which the Company reports a net loss, dilutive securities are excluded from the calculation of diluted net loss per share amounts as the effect would be anti-dilutive. For nine months ended September 30, 2013 and 2012, the following convertible debt and warrants to purchase shares of common stock were excluded from the computation of diluted net loss per share, as the inclusion of such shares would be anti-dilutive:
		Nine Months Ended
		September 30 ,
		2013	2012
	Convertible debt	3,434,844	5,345,623
	Stock warrants	6,106,928	2,198,928
		9,541,772	7,544,551
	Recently Issued Accounting Pronouncements – The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company's results of operations, financial position or cash flow.
	Subsequent Events – The Company has evaluated all transactions occurring from June 30, 2013 through the date of issuance of the consolidated financial statements for disclosure consideration.

INTANGIBLE_ASSET

INTANGIBLE ASSET	9 Months Ended
	Sep. 30, 2013
INTANGIBLE ASSET [Text Block]	'
	NOTE 3 – INTANGIBLE ASSET
	During 2010 and 2011, the Company acquired licensing rights from Nanotech Industries, Inc., (“NTI”, a privately-held entity deemed a related party by virtue of common ownership and control), for the rights to manufacture and distribute environmentally safe coatings (“Coating Products”) using NTI’s technology.
	As part of the original licensing agreement signed on July 12, 2010 (see table below) the Company has the option to obtain rights for the rest of the world on an exclusive perpetual basis, in exchange for the issuance of stock equal to 62.5% of the Company’s total shares. If this option is exercised, NTI would control the Company by virtue of ownership of a majority of the Company’s outstanding shares.
	Following is a summary of the licenses acquired to date from NTI:
														Carrying
												Carrying Value		Value at
			License Rights					Term (date) of		Original		at September		December 31,
			Overview			Licensed Region		License		Cost		30, 2013		2012
	A		Coating Products			North America		June 12, 2010- 6 - years	$	500,000		nil	$	36,463
	B		Coating Products			Russian Territory		March 17, 2011- 10 years	$	150,000	$	35,600	$	39,200
	C		Coating Products			European Continent		July 7, 2011- 5 years	$	1,250,000	$	445,730	$	551,300
	On October 18, 2011, the Company and NTI entered into a second Licensing Agreement (“Second Agreement”) granting the Company option (“Sealant Option”) to be exercised within six months of the signing of the Licensing Agreement, for the manufacturing and sale of environmentally safe adhesives and sealants (“Sealant Products”), for the following:
		1	The Company shall issue to NTI a one-time licensing fee (“Sealant Shares”), an aggregate number of shares of the Company’s restricted common stock which shall give NTI, immediately upon such issuance of shares, an incremental 15% (fifteen percent) ownership stake in the Company.
		2	The Company shall pay to NTI a royalty of 7.5% (seven and one half percent) of gross revenue from the sale of the Sealant Products (“Royalty”) for the duration of this Agreement.
	On December 6, 2011 the Company notified NTI of its election to exercise the option. To date the Company has not issued the Licensing Shares and therefore the Licensing Agreement is not yet effective.
	On June 28, 2013, the Company entered into the Third Amendment of the licensing agreement extending the term for the North American rights by 36 months to June 12, 2016.
	Intangible activity is as follows for the nine months ended September 30, 2013:
	Intangible asset, net as of December 31, 2012	$	626,963
	Purchases		-
	Sale		-
	Impairment		-
	Less: current amortization		(145,633	)
	Total intangible asset, net as of September 30, 2013	$	481,330
	The balance of intangible assets, net is as follows:
			September 30,			December 31,
			2013			2012
	Intangible asset, beginning of period	$	1,118,083		$	1,118,083
	Less: accumulated amortization		(636,753	)		(491,120	)
	Total intangible asset, net	$	481,330		$	626,963
	During the nine months ended September 30, 2013 and 2012 amortization expense was $145,633 and $163,980, respectively.

FAIR_VALUE_MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Sep. 30, 2013
FAIR VALUE MEASUREMENTS [Text Block]	'
	NOTE 4 – FAIR VALUE MEASUREMENTS
	The following table sets forth, by level within the fair value hierarchy, the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of September 30, 2013:
				Quoted Prices			Significant				Total
				in Active			Other		Significant		Carrying
				Markets for			Observable		Unobservable		Value as of
				Identical Assets			Inputs		Inputs		September 30,
	Description			(Level 1)			(Level 2)		(Level 3)		2013
	Derivative liabilities – Senior secured convertible debenture		$	-		$	-	$	119,279	$	119,279
	The following table sets forth a reconciliation of changes in the fair value of financial assets and liabilities classified as Level 3 in the fair value hierarchy:
			Significant Unobservable Inputs
			(Level 3)
			Nine Months Ended
			September 30,
			2013			2012
	Beginning balance	$	166,721		$	480,461
	Total (gains) and losses		(47,442	)		(394,850	)
	Settlements		-			-
	Additions		-			46,721
	Transfers		-			-
	Ending balance	$	119,279		$	132,332
	Change in unrealized gains (losses) included in earnings relating to derivatives still held as of September 30, 2013 and 2012	$	47,442		$	394,850

SENIOR_SECURED_CONVERTIBLE_DEB

SENIOR SECURED CONVERTIBLE DEBENTURES	9 Months Ended
	Sep. 30, 2013
SENIOR SECURED CONVERTIBLE DEBENTURES [Text Block]	'
	NOTE 5 – SENIOR SECURED CONVERTIBLE DEBENTURES
	On August 16, 2010, the Company entered into a securities purchase agreement with a third party for the subscription of senior secured convertible debentures (“SSCD”) for an amount of $400,000. The debentures had a maturity date of August 16, 2012 with a coupon of 10% and convert at the option of the holder into shares of common stock of the Company at a price of $0.75 per share. The notes are secured by all assets of the Company. The subscriber also received 533,336 Series A warrants with a maturity of 1 year and an exercise price of $1.25 per share and 133,360 Series B warrants with a term of 3 years and an exercise price of $1.50 per share. The Company amended the terms of the Series A warrants during the nine months ended September 30, 2013. See Note 10. The debentures and Series A warrants carry registration rights whereby upon the consummation of the reverse merger with Nanotech, the shares underlying the debentures and Series A warrants will be registered as soon as is practicable. All prices and warrants issued have been adjusted for the post-acquisition of Nanotech by HCT.
	The Company is in default of payment of the debentures which matured on August 16, 2012. No notices have been received from the debenture holder.
	The obligations of the Company under the SSCD will rank senior to all outstanding and future indebtedness of the Company and shall be secured by a first priority, perfected security interest in all the assets of the Company.

LOAN_PAYABLE

LOAN PAYABLE	9 Months Ended
	Sep. 30, 2013
LOAN PAYABLE [Text Block]	'
	NOTE 6 – LOANS PAYABLE
	Loans payable include a loan from a non-related party that was issued for $75,000 on November 16, 2010 and was repayable on May 16, 2011 with a 10% premium. This $7,500 premium has been amortized and on April 29, 2011, the lender converted $55,000 of this debt to convertible debentures. The balance at September 30, 2013 and at December 31, 2012 and 2011 was $27,500, and the loan is currently in default. The Company has not received any notices from the loan holders with respect to the defaults.
	During the nine months ended September 30, 2013, the Company issued a $100,000 loan with a three-month maturity, maturing on August 23, 2013, bearing interest at 16% per annum, payable monthly, with an additional $5,000 premium payable at maturity, a $110,000 loan with a one-year maturity, maturing on March 25, 2014, bearing interest at 16% per annum, payable monthly with an additional 110,000 warrants attached to the loan, a loan was issued for $8,500 maturing in July 2013 bearing interest of 15% per annum and a $50,000 loan bearing interest at 15% per annum.
	The fair value of these 110,000 warrants issued in conjunction with this debt amounted to $30,217 using the assumptions discussed in the table below. This resulted in a relative fair value of $23,705 which was recorded as a debt discount and a corresponding increase in paid-in capital. The discount is amortized over the life of the associated loan payable.
	Expected volatility		120%
	Exercise price	$	1
	Stock price	$	0.38
	Expected life		5 years
	Risk-free interest rate		0.80%
	Dividend yield	$	Nil
	In 2012 the Company entered into various loans agreements totaling $681,500 at interest rates ranging from 15%- 25%. Several loans totaling $709,000 are in default. The creditors have not demanded payment of these loans.
	During the year ended December 31, 2012, the Company issued 50,000 warrants related to a loan payable. The fair value of the 50,000 warrants issued in conjunction with the debt issued in 2012 amounted to $19,005 using the assumptions discussed in the table below. This resulted in a relative fair value of $16,668 which was recorded as a debt discount. The discount is amortized over the life of the associated loan payable.
	Expected volatility		166.04%
	Exercise price	$	0.5
	Stock price	$	0.5
	Expected life		2 years
	Risk-free interest rate		0.25%
	Dividend yield	$	nil
	The Company recorded $4,259 and $26,913 of interest expense related to the debt discount during the three and nine months ended September 30, 2013. There was no corresponding debt discount during the three and six months ended September 30, 2012. During the nine months ended September 30, 2013 and 2012 total interest expense was $110,802 and $31,200 respectively, and the total interest paid was $55,173 and $11,169 respectively. At September 30, 2013 the unamortized debt discount was $11,430 compared to $14,638 as of December 31, 2012.

LOANS_PAYABLE_SHAREHOLDERS

LOANS PAYABLE SHAREHOLDERS	9 Months Ended
	Sep. 30, 2013
LOANS PAYABLE SHAREHOLDERS [Text Block]	'
	NOTE 7 – LOANS PAYABLE –SHAREHOLDERS
	During the years ended December 31, 2012 and 2011, the Company entered into various loan agreements and arrangements for loans with certain shareholders totaling $894,000 and $765,296, respectively, all having different maturity dates from 2011 to 2013. Several of these loans totaling $896,382 are in default. The shareholders have not demanded payment of these loans.
	During the nine months ended September 30, 2013, the Company received $592,648 in shareholder loans and repaid $335,630. In addition the Company repaid an additional $125,022 through the issuance of 933,000 warrants. The fair value of the warrants was $307,144. The Company recorded a loss on settlement of debt in the amount of $182,122 and an increase in paid-in capital of $307,144.
	The fair-value of these 933,000 warrants was determined using the assumptions in the table below:
	Expected volatility		128.26%
	Exercise price	$	0.001
	Stock price	$	0.33
	Expected life		5 years
	Risk-free interest rate		1.01%
	Dividend yield	$	nil
	On January 1, 2013, the Company entered into a new loan agreement with a shareholder with a maturity of December 31, 2013. The new loan agreement for $130,000 cancelled the previous loan agreement for $100,000 that had expired. The Company recorded a loss on extinguishment of debt of $10,169 and a debt discount of $19,831. The Company is amortizing the debt discount over the life of the loan payable. The Company has recorded $14,874 of interest expense related to the amortization of the debt discount for the nine months ended September 30, 2013. At September 30, 2013 there remains an unamortized discount of $4,957. In addition 25,000 warrants were issued.
	The fair value of these 25,000 warrants issued in conjunction with this debt amounted to $9,840 using the assumptions discussed in the table below. This resulted in a relative fair value of $9,148 which was recorded as an additional debt discount and a corresponding increase in paid –up capital. The discount is amortized over the life of the associated loan payable. Interest expense of $6,861 was recorded from amortization of the debt discount, resulting in an unamortized discount of $2,287 at September 30, 2013.
	Expected volatility		399.77%
	Exercise price	$	0.01
	Stock price	$	0.4
	Expected life		2 years
	Risk-free interest rate		0.27%
	Dividend yield	$	nil
	On January 21, 2013, the Company entered in a loan agreement for $78,400 CDN. At September 30, 2013, the value was $76,032 US. The loan matured on July 20, 2013 and bears interest at 2% per month, payable monthly, unpaid amounts bear interest at 2.5% per month. The loan is secured by the Company’s assets for approximately $94,000. Interest of $10,908 has been recorded and paid through the issuance of 36,360 shares of common stock. The loan is in default and no notice of demand for repayment has been given to the Company.
	The Company recorded $15,781 and $48,802 of interest expense related to the debt discount during the three and nine months ended September 30, 2013. The corresponding debt discount during the three and nine months ended September 30, 2012 was $12,193 and $42,929. During the nine months ended September 30, 2013 and 2012 total interest expense was $61,818 and $59,941 respectively, and the total interest paid was $30,492 and $42,740 respectively. At September 30, 2013 the unamortized debt discount was $11,710 compared to $31,533 as of December 31, 2012.

NOTE_PAYABLE_RELATED_PARTY

NOTE PAYABLE RELATED PARTY	9 Months Ended
	Sep. 30, 2013
NOTE PAYABLE RELATED PARTY [Text Block]	'
	NOTE 8 – NOTE PAYABLE – RELATED PARTY
	During the nine months ended September 30, 2013, the Company made principal payments of $97,130 on its note payable to NTI related to the 2011 acquisition of the license rights for coating products in Europe. The note matures on November 29, 2013, does not bear interest, and no payments are required prior to maturity. The balance of the note is $703,351 and $800,481 at September 30, 2013 and December 31, 2012, respectively.

CONVERTIBLE_DEBENTURES

CONVERTIBLE DEBENTURES	9 Months Ended
	Sep. 30, 2013
CONVERTIBLE DEBENTURES [Text Block]	'
	NOTE 9 –CONVERTIBLE DEBENTURES
	On April 29, 2011, the Company issued convertible debentures for proceeds of $1,201,000 and on February 21, 2012, issued an additional $119,500 (“Debentures”) with a maturity of 36 months and a coupon rate of 10% per annum payable in cash or capital stock at the Company’s discretion. The debentures are held by third parties and by non-controlling shareholders, and are convertible as follows:
	April 29, 2014 convertible debentures
	-by dividing the conversion amount by a conversion factor of 1.4 yielding Units of the Company where each Unit (at a price of $1.40 per Unit), is comprised of 1 share of common stock and one half of a warrant to purchase a share of common stock of the Company with an exercise price of $2.00 per share and a maturity at April 29, 2014. Warrants are exercisable at the option of the holder at any time prior to maturity.
	February 21, 2015 convertible debentures:
	-by dividing the conversion amount by a conversion factor of 1.45 yielding Units of the Company where each Unit (at a price of $1.45 per Unit), is comprised of 1 share of common stock and one half of a warrant to purchase a share of common stock of the Company with an exercise price of $2.10 per share and a maturity at February 21, 2015. Warrants are exercisable at the option of the holder at any time prior to maturity.
	Both debentures carry an anti-dilution provision. The conversion price applicable to the debentures is subject to reset in the event of a Dilutive Issuance (as defined in the debenture agreement) by the Company. A Dilutive Issuance excludes shares or options issued to employees, officers, directors or consultants pursuant to stock option plans approved by the Board of Directors.
	The Company analyzed the financial instruments, (the convertible debenture, share purchase and warrants) in accordance with FASB ASC 815, Fair Value Measurements and Disclosures. The embedded conversion features in the convertible debentures and attached warrants should be accounted for as a derivative liability. The warrants contain full ratchet reset features (subject to adjustment for dilutive share issuances) and should be valued as a derivative liability.
	The valuation of the derivative liability attached to the debentures arrived at through the use of multinomial lattice models based on a probability weighted discounted cash flow model. These models are based on future projections of the various potential outcomes. The features in the note that were analyzed and incorporated into the model included the conversion feature with the reset provisions and the call/redemption options. Based on these features, there are six primary events that can occur: payments are made in cash; payments are made with stock; the holder converts upon receiving a change notice; the holder converts the note; the Issuer redeems the note; or the Company defaults on the note.
	The model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. interest rates, stock price, conversion price, etc.). Projections were then made on these underlying factors which led to a set of potential scenarios. Probabilities were assigned to each of these scenarios over the remaining term of the note based on management projections. This led to a cash flow projection over the life of the note and a probability associated with that cash flow. A discounted weighted average cash flow over the various scenarios was completed, and it was compared to the discounted cash flow of the note without the embedded features, thus determining a value for the derivative liability of $558,248 as of April 29, 2011 and of $46,721 at February 21, 2012 for each issuance. The Company recorded the change in the fair value of the derivative liability as a gain of $77,787 as of December 31, 2011, to reflect the value of the derivative liability as $480,461. The Company recorded another gain of $360,461 to reflect the value of the derivative liability as $166,721 as of December 31, 2012. To reflect the change in fair value for the nine-month period ended September 30, 2013 the Company recorded a gain of $47,442.
	The Company recorded a corresponding discount of $46,721 and $558,248 against the carrying value of the convertible debentures during the years ended December 31, 2012 and 2011, respectively. The discounts are amortized using the effective interest method over the three year term of the debt. Amortization of the debt discount was $164,823 and $132,815 for the nine months ended September 30, 2013 and 2012, respectively, leaving a remaining discount of $160,313 at September 30, 2013.
	Interest of $98,766 has been recorded as of September 30, 2013. During 2013, $11,949 in interest has been paid through the issuance of 29,875 shares of common stock issued to the February 21 Debenture holders. The Debenture holders participating in the April 29, 2011 offering received 390,692 common shares on April 29, 2013 for payment of $128,928 in interest. The balance of the debentures at September 30, 2013 and December 31, 2012, net of the unamortized discount, was $1,160,187 and $995,364, respectively.

STOCKHOLDERS_DEFICIT

STOCKHOLDERS DEFICIT	9 Months Ended
	Sep. 30, 2013
STOCKHOLDERS DEFICIT [Text Block]	'
	NOTE 10– STOCKHOLDERS’ DEFICIT
	On February 22, 2012, the Company entered an agreement with a shareholder whereby a loan premium of 10,000 shares would be issued to the shareholder. Although the shares had not been issued the Company has recorded a reduction of the loan and an increase in stock payable of $15,000. The fair value of the stock was determined using the stock price on the date of grant.
	During the nine months ended September 30, 2013 , the Company issued 129,000 shares to shareholder creditors and a consultant as payment for services with a fair value of $50,500, 420,567 shares to convertible debenture holders as payment of interest for the year of $140,878, 100,000 to the Senior Secured Debenture Holder for payment of interest of $38,000, 36,360 shares to a shareholder- creditor for accrued interest of $10,908, and 1,625,000 shares to a shareholder-creditor and a related party for payment of $594,000 against accounts payable and accrued liabilities related parties and recognized a loss on settlement in the amount of $101,500.
	In addition, during the nine months ended September 30, 2013, a warrant holder exercised 70,000 warrants for 69,788 shares on a cashless basis with a reduction in additional paid in capital of $70.
	During the nine months ended September 30 2013, the Company issued 1,650,000 warrants to shareholders for consulting services at a fair value of $604,332 (recorded as stock-based compensation), and 450,000 warrants to a related party landlord as payment for rent with a fair value of $202,095 (recorded as an adjustment to accounts payable of $93,750, prepaid expense of $22,500 and stock based compensation of $85,845), 933,000 warrants to a shareholder to pay a shareholder loan with a fair value of $334,222 (recorded as an adjustment to loans payable-shareholders of $130,100 and loss on extinguishment of debt of $204,222), 110,000 warrants in connection with a loan from a third party with a relative fair value of $23,705 (recorded as debt discount), and 25,000 warrants in connection with a loan from a shareholder with a relative fair value of $9,148 (recorded as debt discount), all with a corresponding increase in additional paid-in capital using the Black-Scholes method according to the following assumptions:
	Expected volatility		118.89%- 128.26%
	Exercise price	$	0.001 - $1.00
	Stock price	$	0.27 -$0.45
	Expected life		2 - 5 years
	Risk-free interest rate		0.27%- 1.01%
	Dividend yield	$	Nil
	On June 28, 2013, the Company extended the expiration date of common stock purchase warrants described below to February 28, 2018. This extension of the expiration date will apply to the following warrants: (i) the 533,336 Series A warrants issued to a third party pursuant to a securities purchase agreement entered into on August 16, 2010; (ii) the 687,500 stock purchase issued to a consultant on July 14, 2010; and (iii) the 50,000 stock purchase warrants issued pursuant to a loan agreement on November 29, 2012. The Company also agreed to reduce the exercise price of the 533,336 Series A warrants from $1.25 per share to $0.39 per share.
	The modification of the maturity and exercise price of the above warrants resulted in a fair value of $241,697 which was recorded as a loss on modification with a corresponding increase in additional paid-in capital using the Black-Scholes method according to the following assumptions:
	Expected volatility		128.26% - 152.79%
	Exercise price	$	0.39 -$0.50
	Stock price	$	0.39
	Expected life		0.67 - 4.67 years
	Risk-free interest rate		0.15% - 0.41%
	Dividend yield	$	Nil
	During the quarter ended September 30, 2013, the Company issued 830,000 warrants for services, which was recorded as option related compensation of $310,776 with a corresponding increase in additional paid-in capital using the Black-Scholes method according to the following assumptions:
	Expected volatility		118.56% - 128.26%
	Exercise price	$	0.001 -$0.75
	Stock price	$	0.39 -$0.42
	Expected life		5 years
	Risk-free interest rate		1.39% - 1.54%
	Dividend yield	$	Nil
	Warrants
	A summary of the activity in the Company's warrants during the nine months ended September 30, 2013 is presented below:
			Number of			Weighted Average
			Warrants			Exercise Price
	Outstanding and exercisable, at December 31, 2012		2,318,928		$	0.29
	Issued January 1, 2013		25,000		$	0.01
	Issued March 1, 2013		450,000		$	0.001
	Issued March 14, 2013		420,000		$	0.001
	Issued March 25, 2013		110,000		$	1
	Issued April 5, 2013		480,000		$	0.001
	Issued May 30, 2013		1,683,000		$	0.001
	Issued July 1 ,2013		200,000		$	0.2
	Issued July 10 ,2013		230,000		$	0.65
	Issued August 15,2013		400,000		$	0.001
	Exercised		(70,000	)	$	0.001
	Expired		(140,000	)	$	1.48
	Outstanding and exercisable, at September 30, 2013		6,106,928		$	0.12
	In addition to the regular warrants detailed in the table above, there are issued and outstanding 533,336 Series A warrants with an exercise price of $0.39 per share and 133,336 Series B warrants with an exercise price of $1.50 per share mentioned above.
	The intrinsic value of warrants outstanding at September 30, 2013 was $1,490,696.
	Contingent Option Issuance
	On July 20, 2012, the Company’s board of directors approved the issuance of 300,000 stock purchase options, exercise price of $0.001 per share and five-year life, from date of issuance, to the Company’s President, Joseph Kristul, contingent on his successful negotiation of a major sales contract. The major sales contract agreement has not yet been reached by the Company.

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2013
RELATED PARTY TRANSACTIONS [Text Block]	'
	NOTE 11– RELATED PARTY TRANSACTIONS
	Fees charged by Shareholder
	During the nine months ended September 30, 2013 and 2012, the Company was charged $398,000 and $223,000, respectively, by an outside consultant, who is also a shareholder, for professional fees, expenses and commissions. The amounts are included in accounts payable and accrued liabilities related parties.
	Shared Administrative Costs
	The Company shares office space and certain personnel with NTI. Costs are allocated among the parties based on usage. During 2013 and 2012, the allocation of such shared costs between the Company and NTI was 80% and 20%, respectively.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2013
SUBSEQUENT EVENTS [Text Block]	'
	NOTE 12– SUBSEQUENT EVENTS
	Subsequent to quarter ended September 30, 2013, the Company has issued 200,000 shares to consultants for services at a fair value of $60,000.  The fair value of the stock was based on the market price on the date of grant.

Recovered_Sheet1

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2013
Basis of Presentation [Policy Text Block]	'
	Basis of Presentation - The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars. The Company’s fiscal year end is December 31.
Principles of consolidation [Policy Text Block]	'
	Principles of consolidation - The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Nanotech Industries International Inc., (“Nanotech”). All significant inter-company balances and transactions have been eliminated in the consolidated financial statements.
Development Stage [Policy Text Block]	'
	Development Stage – The Company complies with Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 915 “Development Stage Entities” in its characterization of the Company as a development stage enterprise.
Use of estimates [Policy Text Block]	'
	Use of estimates – The preparation of financial statements in conformity with generally accepted accounting principles requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates.
Revenue recognition [Policy Text Block]	'
	Revenue recognition – Revenue is recognized when persuasive evidence of an arrangement exists, goods are delivered, sales price is determinable, and collection is reasonably assured.
Stock-Based Compensation [Policy Text Block]	'
	Stock-Based Compensation – For stock and stock options awarded in return for services rendered, the expense is measured at the grant-date fair value of the award and recognized as compensation expense on a straight-line basis over the service period, which is the vesting period. The Company estimates forfeitures that it expects will occur and records expense based upon the number of awards expected to vest.
Fair Value Measurements [Policy Text Block]	'
	Fair Value Measurements - Fair value is the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value measurements are classified and disclosed in one of the following categories:
	Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. The Company considers active markets as those in which transactions for the assets or liabilities occur in sufficient frequency and volume to provide pricing information on an ongoing basis.
	Level 2: Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability. This category includes those derivative instruments that the Company values using observable market data. Substantially all of these inputs are observable in the marketplace throughout the term of the derivative instruments, can be derived from observable data, or supported by observable levels at which transactions are executed in the marketplace.
	Level 3: Measured based on prices or valuation models that require inputs that are both significant to the fair value measurement and less observable from objective sources (i.e. supported by little or no market activity). The Company’s valuation models are primarily industry standard models. Level 3 instruments include derivative warrant instruments. The Company does not have sufficient corroborating evidence to support classifying these assets and liabilities as Level 1 or Level 2.
	Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels. The estimated fair value of the derivative warrant instruments was calculated using a modified lattice valuation model.
Earnings (Loss) per Share [Policy Text Block]	'
	Earnings (Loss) per Share - Basic net loss per share amounts are computed by dividing the net loss by the weighted average number of common shares outstanding over the reporting period. In periods in which the Company reports a net loss, dilutive securities are excluded from the calculation of diluted net loss per share amounts as the effect would be anti-dilutive. For nine months ended September 30, 2013 and 2012, the following convertible debt and warrants to purchase shares of common stock were excluded from the computation of diluted net loss per share, as the inclusion of such shares would be anti-dilutive:
		Nine Months Ended
		September 30 ,
		2013	2012
	Convertible debt	3,434,844	5,345,623
	Stock warrants	6,106,928	2,198,928
		9,541,772	7,544,551
Recently Issued Accounting Pronouncements [Policy Text Block]	'
	Recently Issued Accounting Pronouncements – The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company's results of operations, financial position or cash flow.
Subsequent Events [Policy Text Block]	'
	Subsequent Events – The Company has evaluated all transactions occurring from June 30, 2013 through the date of issuance of the consolidated financial statements for disclosure consideration.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2013
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	'
		Nine Months Ended
		September 30 ,
		2013	2012
	Convertible debt	3,434,844	5,345,623
	Stock warrants	6,106,928	2,198,928
		9,541,772	7,544,551

INTANGIBLE_ASSET_Tables

INTANGIBLE ASSET (Tables)	9 Months Ended
	Sep. 30, 2013
Schedule of License Acquired From NTI [Table Text Block]	'
														Carrying
												Carrying Value		Value at
			License Rights					Term (date) of		Original		at September		December 31,
			Overview			Licensed Region		License		Cost		30, 2013		2012
	A		Coating Products			North America		June 12, 2010- 6 - years	$	500,000		nil	$	36,463
	B		Coating Products			Russian Territory		March 17, 2011- 10 years	$	150,000	$	35,600	$	39,200
	C		Coating Products			European Continent		July 7, 2011- 5 years	$	1,250,000	$	445,730	$	551,300
Schedule of lntangibles Activity [Table Text Block]	'
	Intangible asset, net as of December 31, 2012	$	626,963
	Purchases		-
	Sale		-
	Impairment		-
	Less: current amortization		(145,633	)
	Total intangible asset, net as of September 30, 2013	$	481,330
Schedule of Intangible Assets [Table Text Block]	'
			September 30,			December 31,
			2013			2012
	Intangible asset, beginning of period	$	1,118,083		$	1,118,083
	Less: accumulated amortization		(636,753	)		(491,120	)
	Total intangible asset, net	$	481,330		$	626,963

FAIR_VALUE_MEASUREMENTS_Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Sep. 30, 2013
Schedule of Fair Value of Financial Instruments [Table Text Block]	'
				Quoted Prices			Significant				Total
				in Active			Other		Significant		Carrying
				Markets for			Observable		Unobservable		Value as of
				Identical Assets			Inputs		Inputs		September 30,
	Description			(Level 1)			(Level 2)		(Level 3)		2013
	Derivative liabilities – Senior secured convertible debenture		$	-		$	-	$	119,279	$	119,279
Schedule of Reconciliation of Changes in the Fair Value of Financial Assets and Liabilities [Table Text Block]	'
			Significant Unobservable Inputs
			(Level 3)
			Nine Months Ended
			September 30,
			2013			2012
	Beginning balance	$	166,721		$	480,461
	Total (gains) and losses		(47,442	)		(394,850	)
	Settlements		-			-
	Additions		-			46,721
	Transfers		-			-
	Ending balance	$	119,279		$	132,332
	Change in unrealized gains (losses) included in earnings relating to derivatives still held as of September 30, 2013 and 2012	$	47,442		$	394,850

LOAN_PAYABLE_Tables

LOAN PAYABLE (Tables)	9 Months Ended			12 Months Ended
	Sep. 30, 2013			Dec. 31, 2012
Schedule of Debt Issued in 2013 and 2012 using the following assumptions [Table Text Block]	'			'
	Expected volatility		120%	Expected volatility		166.04%
	Exercise price	$	1	Exercise price	$	0.5
	Stock price	$	0.38	Stock price	$	0.5
	Expected life		5 years	Expected life		2 years
	Risk-free interest rate		0.80%	Risk-free interest rate		0.25%
	Dividend yield	$	Nil	Dividend yield	$	nil

LOANS_PAYABLE_SHAREHOLDERS_Tab

LOANS PAYABLE SHAREHOLDERS (Tables)	9 Months Ended
	Sep. 30, 2013
Schedule of fair-value of 933,000 warrants using the following assumptions [Table Text Block]	'
	Expected volatility		128.26%
	Exercise price	$	0.001
	Stock price	$	0.33
	Expected life		5 years
	Risk-free interest rate		1.01%
	Dividend yield	$	nil
Schedule of fair-value of 25,000 warrants using the following assumptions [Table Text Block]	'
	Expected volatility		399.77%
	Exercise price	$	0.01
	Stock price	$	0.4
	Expected life		2 years
	Risk-free interest rate		0.27%
	Dividend yield	$	nil

STOCKHOLDERS_DEFICIT_Tables

STOCKHOLDERS DEFICIT (Tables)	9 Months Ended
	Sep. 30, 2013
Schedule of Warrants Valuation Assumptions [Table Text Block]	'
	Expected volatility		118.89%- 128.26%
	Exercise price	$	0.001 - $1.00
	Stock price	$	0.27 -$0.45
	Expected life		2 - 5 years
	Risk-free interest rate		0.27%- 1.01%
	Dividend yield	$	Nil
Schedule of Warrants Valuation assumptions resulted in a fair value of $241,697 [Table Text Block]	'
	Expected volatility		128.26% - 152.79%
	Exercise price	$	0.39 -$0.50
	Stock price	$	0.39
	Expected life		0.67 - 4.67 years
	Risk-free interest rate		0.15% - 0.41%
	Dividend yield	$	Nil
Schedule of Fair Value Assumptions used for Warrants Issued for Services [Table Text Block]	'
	Expected volatility		118.56% - 128.26%
	Exercise price	$	0.001 -$0.75
	Stock price	$	0.39 -$0.42
	Expected life		5 years
	Risk-free interest rate		1.39% - 1.54%
	Dividend yield	$	Nil
Schedule of Warrants Activity [Table Text Block]	'
			Number of			Weighted Average
			Warrants			Exercise Price
	Outstanding and exercisable, at December 31, 2012		2,318,928		$	0.29
	Issued January 1, 2013		25,000		$	0.01
	Issued March 1, 2013		450,000		$	0.001
	Issued March 14, 2013		420,000		$	0.001
	Issued March 25, 2013		110,000		$	1
	Issued April 5, 2013		480,000		$	0.001
	Issued May 30, 2013		1,683,000		$	0.001
	Issued July 1 ,2013		200,000		$	0.2
	Issued July 10 ,2013		230,000		$	0.65
	Issued August 15,2013		400,000		$	0.001
	Exercised		(70,000	)	$	0.001
	Expired		(140,000	)	$	1.48
	Outstanding and exercisable, at September 30, 2013		6,106,928		$	0.12

NATURE_OF_BUSINESS_AND_BASIS_O1

NATURE OF BUSINESS AND BASIS OF PRESENTATION (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Nature Of Business And Basis Of Presentation 1	$14,144,000
Nature Of Business And Basis Of Presentation 2	$4,026,000

INTANGIBLE_ASSET_Narrative_Det

INTANGIBLE ASSET (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
	M
Intangible Asset 1	62.50%
Intangible Asset 2	15.00%
Intangible Asset 3	7.50%
Intangible Asset 4	36
Intangible Asset 5	$145,633
Intangible Asset 6	$163,980

SENIOR_SECURED_CONVERTIBLE_DEB1

SENIOR SECURED CONVERTIBLE DEBENTURES (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
	Y
Senior Secured Convertible Debentures 1	$400,000
Senior Secured Convertible Debentures 2	10.00%
Senior Secured Convertible Debentures 3	$0.75
Senior Secured Convertible Debentures 4	533,336
Senior Secured Convertible Debentures 5	1
Senior Secured Convertible Debentures 6	$1.25
Senior Secured Convertible Debentures 7	133,360
Senior Secured Convertible Debentures 8	3
Senior Secured Convertible Debentures 9	$1.50

LOAN_PAYABLE_Narrative_Details

LOAN PAYABLE (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Loan Payable 1	$75,000
Loan Payable 2	10.00%
Loan Payable 3	7,500
Loan Payable 4	55,000
Loan Payable 5	27,500
Loan Payable 6	100,000
Loan Payable 7	16.00%
Loan Payable 8	5,000
Loan Payable 9	110,000
Loan Payable 10	16.00%
Loan Payable 11	110,000
Loan Payable 12	8,500
Loan Payable 13	15.00%
Loan Payable 14	50,000
Loan Payable 15	15.00%
Loan Payable 16	110,000
Loan Payable 17	30,217
Loan Payable 18	23,705
Loan Payable 19	681,500
Loan Payable 20	15.00%
Loan Payable 21	25.00%
Loan Payable 21	709,000
Loan Payable 22	50,000
Loan Payable 23	50,000
Loan Payable 24	19,005
Loan Payable 25	16,668
Loan Payable 26	4,259
Loan Payable 27	26,913
Loan Payable 28	110,802
Loan Payable 29	31,200
Loan Payable 30	55,173
Loan Payable 31	11,169
Loan Payable 32	11,430
Loan Payable 33	$14,638

LOANS_PAYABLE_SHAREHOLDERS_Nar

LOANS PAYABLE SHAREHOLDERS (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Loans Payable Shareholders 1	$894,000
Loans Payable Shareholders 2	765,296
Loans Payable Shareholders 3	896,382
Loans Payable Shareholders 4	592,648
Loans Payable Shareholders 5	335,630
Loans Payable Shareholders 6	125,022
Loans Payable Shareholders 7	933,000
Loans Payable Shareholders 8	307,144
Loans Payable Shareholders 9	182,122
Loans Payable Shareholders 10	307,144
Loans Payable Shareholders 11	933,000
Loans Payable Shareholders 12	130,000
Loans Payable Shareholders 13	100,000
Loans Payable Shareholders 14	10,169
Loans Payable Shareholders 15	19,831
Loans Payable Shareholders 16	14,874
Loans Payable Shareholders 17	4,957
Loans Payable Shareholders 18	25,000
Loans Payable Shareholders 19	25,000
Loans Payable Shareholders 20	9,840
Loans Payable Shareholders 21	9,148
Loans Payable Shareholders 22	6,861
Loans Payable Shareholders 23	2,287
Loans Payable Shareholders 24	78,400
Loans Payable Shareholders 25	76,032
Loans Payable Shareholders 26	2.00%
Loans Payable Shareholders 27	2.50%
Loans Payable Shareholders 28	94,000
Loans Payable Shareholders 29	10,908
Loans Payable Shareholders 30	36,360
Loans Payable Shareholders 31	15,781
Loans Payable Shareholders 32	48,802
Loans Payable Shareholders 33	12,193
Loans Payable Shareholders 34	42,929
Loans Payable Shareholders 35	61,818
Loans Payable Shareholders 36	59,941
Loans Payable Shareholders 37	30,492
Loans Payable Shareholders 38	42,740
Loans Payable Shareholders 39	11,710
Loans Payable Shareholders 40	$31,533

NOTE_PAYABLE_RELATED_PARTY_Nar

NOTE PAYABLE RELATED PARTY (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Note Payable Related Party 1	$97,130
Note Payable Related Party 2	703,351
Note Payable Related Party 3	$800,481

CONVERTIBLE_DEBENTURES_Narrati

CONVERTIBLE DEBENTURES (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
	M
Convertible Debentures 1	$1,201,000
Convertible Debentures 2	119,500
Convertible Debentures 3	36
Convertible Debentures 4	10.00%
Convertible Debentures 5	1.4
Convertible Debentures 6	1.4
Convertible Debentures 7	1
Convertible Debentures 8	$2
Convertible Debentures 9	1.45
Convertible Debentures 10	1.45
Convertible Debentures 11	1
Convertible Debentures 12	$2.10
Convertible Debentures 13	558,248
Convertible Debentures 14	46,721
Convertible Debentures 15	77,787
Convertible Debentures 16	480,461
Convertible Debentures 17	360,461
Convertible Debentures 18	166,721
Convertible Debentures 19	47,442
Convertible Debentures 20	46,721
Convertible Debentures 21	558,248
Convertible Debentures 22	164,823
Convertible Debentures 23	132,815
Convertible Debentures 24	160,313
Convertible Debentures 25	98,766
Convertible Debentures 26	11,949
Convertible Debentures 27	29,875
Convertible Debentures 28	390,692
Convertible Debentures 29	128,928
Convertible Debentures 30	1,160,187
Convertible Debentures 31	$995,364

STOCKHOLDERS_DEFICIT_Narrative

STOCKHOLDERS DEFICIT (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Stockholders Deficit 1	10,000
Stockholders Deficit 2	$15,000
Stockholders Deficit 3	129,000
Stockholders Deficit 4	50,500
Stockholders Deficit 5	420,567
Stockholders Deficit 6	140,878
Stockholders Deficit 7	100,000
Stockholders Deficit 8	38,000
Stockholders Deficit 9	36,360
Stockholders Deficit 10	10,908
Stockholders Deficit 11	1,625,000
Stockholders Deficit 12	594,000
Stockholders Deficit 13	101,500
Stockholders Deficit 14	70,000
Stockholders Deficit 15	69,788
Stockholders Deficit 16	70
Stockholders Deficit 17	1,650,000
Stockholders Deficit 18	604,332
Stockholders Deficit 19	450,000
Stockholders Deficit 20	202,095
Stockholders Deficit 21	93,750
Stockholders Deficit 22	22,500
Stockholders Deficit 23	85,845
Stockholders Deficit 24	933,000
Stockholders Deficit 25	334,222
Stockholders Deficit 26	130,100
Stockholders Deficit 27	204,222
Stockholders Deficit 28	110,000
Stockholders Deficit 29	23,705
Stockholders Deficit 30	25,000
Stockholders Deficit 31	9,148
Stockholders Deficit 32	533,336
Stockholders Deficit 33	687,500
Stockholders Deficit 34	50,000
Stockholders Deficit 35	533,336
Stockholders Deficit 36	$1.25
Stockholders Deficit 37	$0.39
Stockholders Deficit 38	241,697
Stockholders Deficit 39	830,000
Stockholders Deficit 40	310,776
Stockholders Deficit 41	533,336
Stockholders Deficit 42	$0.39
Stockholders Deficit 43	133,336
Stockholders Deficit 44	$1.50
Stockholders Deficit 45	$1,490,696
Stockholders Deficit 46	300,000
Stockholders Deficit 47	$0.00

RELATED_PARTY_TRANSACTIONS_Nar

RELATED PARTY TRANSACTIONS (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Related Party Transactions 1	$398,000
Related Party Transactions 2	$223,000
Related Party Transactions 3	80.00%
Related Party Transactions 4	20.00%

SUBSEQUENT_EVENTS_Narrative_De

SUBSEQUENT EVENTS (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Subsequent Events 1	200,000
Subsequent Events 2	$60,000

Schedule_of_Antidilutive_Secur

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Summary Of Significant Accounting Policies Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share 1	$3,434,844
Summary Of Significant Accounting Policies Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share 2	5,345,623
Summary Of Significant Accounting Policies Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share 3	6,106,928
Summary Of Significant Accounting Policies Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share 4	2,198,928
Summary Of Significant Accounting Policies Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share 5	9,541,772
Summary Of Significant Accounting Policies Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share 6	$7,544,551

Schedule_of_License_Acquired_F

Schedule of License Acquired From NTI (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
	Y
Intangible Asset Schedule Of License Acquired From Nti 1	$6
Intangible Asset Schedule Of License Acquired From Nti 2	500,000
Intangible Asset Schedule Of License Acquired From Nti 3	0
Intangible Asset Schedule Of License Acquired From Nti 4	36,463
Intangible Asset Schedule Of License Acquired From Nti 5	10
Intangible Asset Schedule Of License Acquired From Nti 6	150,000
Intangible Asset Schedule Of License Acquired From Nti 7	35,600
Intangible Asset Schedule Of License Acquired From Nti 8	39,200
Intangible Asset Schedule Of License Acquired From Nti 9	5
Intangible Asset Schedule Of License Acquired From Nti 10	1,250,000
Intangible Asset Schedule Of License Acquired From Nti 11	445,730
Intangible Asset Schedule Of License Acquired From Nti 12	$551,300

Schedule_of_lntangibles_Activi

Schedule of lntangibles Activity (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Intangible Asset Schedule Of Lntangibles Activity 1	$626,963
Intangible Asset Schedule Of Lntangibles Activity 2	0
Intangible Asset Schedule Of Lntangibles Activity 3	0
Intangible Asset Schedule Of Lntangibles Activity 4	0
Intangible Asset Schedule Of Lntangibles Activity 5	-145,633
Intangible Asset Schedule Of Lntangibles Activity 6	$481,330

Schedule_of_Intangible_Assets_

Schedule of Intangible Assets (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Intangible Asset Schedule Of Intangible Assets 1	$1,118,083
Intangible Asset Schedule Of Intangible Assets 2	1,118,083
Intangible Asset Schedule Of Intangible Assets 3	-636,753
Intangible Asset Schedule Of Intangible Assets 4	-491,120
Intangible Asset Schedule Of Intangible Assets 5	481,330
Intangible Asset Schedule Of Intangible Assets 6	$626,963

Schedule_of_Fair_Value_of_Fina

Schedule of Fair Value of Financial Instruments (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Fair Value Measurements Schedule Of Fair Value Of Financial Instruments 1	$0
Fair Value Measurements Schedule Of Fair Value Of Financial Instruments 2	0
Fair Value Measurements Schedule Of Fair Value Of Financial Instruments 3	119,279
Fair Value Measurements Schedule Of Fair Value Of Financial Instruments 4	$119,279

Schedule_of_Reconciliation_of_

Schedule of Reconciliation of Changes in the Fair Value of Financial Assets and Liabilities (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Fair Value Measurements Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 1	$166,721
Fair Value Measurements Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 2	480,461
Fair Value Measurements Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 3	-47,442
Fair Value Measurements Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 4	-394,850
Fair Value Measurements Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 5	0
Fair Value Measurements Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 6	0
Fair Value Measurements Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 7	0
Fair Value Measurements Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 8	46,721
Fair Value Measurements Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 9	0
Fair Value Measurements Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 10	0
Fair Value Measurements Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 11	119,279
Fair Value Measurements Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 12	132,332
Fair Value Measurements Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 13	47,442
Fair Value Measurements Schedule Of Reconciliation Of Changes In The Fair Value Of Financial Assets And Liabilities 14	$394,850

Schedule_of_Debt_Issued_in_201

Schedule of Debt Issued in 2013 and 2012 using the following assumptions (Details) (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
	Y	Y
Loan Payable Schedule Of Debt Issued In 2013 And 2012 Using The Following Assumptions 1	120.00%	'
Loan Payable Schedule Of Debt Issued In 2013 And 2012 Using The Following Assumptions 2	1	'
Loan Payable Schedule Of Debt Issued In 2013 And 2012 Using The Following Assumptions 3	0.38	'
Loan Payable Schedule Of Debt Issued In 2013 And 2012 Using The Following Assumptions 4	5	'
Loan Payable Schedule Of Debt Issued In 2013 And 2012 Using The Following Assumptions 5	0.80%	'
Loan Payable Schedule Of Debt Issued In 2013 And 2012 Using The Following Assumptions 6	$0	'
Loan Payable Schedule Of Debt Issued In 2013 And 2012 Using The Following Assumptions 1	'	166.04%
Loan Payable Schedule Of Debt Issued In 2013 And 2012 Using The Following Assumptions 2	'	0.5
Loan Payable Schedule Of Debt Issued In 2013 And 2012 Using The Following Assumptions 3	'	0.5
Loan Payable Schedule Of Debt Issued In 2013 And 2012 Using The Following Assumptions 4	'	2
Loan Payable Schedule Of Debt Issued In 2013 And 2012 Using The Following Assumptions 5	'	0.25%
Loan Payable Schedule Of Debt Issued In 2013 And 2012 Using The Following Assumptions 6	'	$0

Schedule_of_fairvalue_of_93300

Schedule of fair-value of 933,000 warrants using the following assumptions (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
	Y
Loans Payable Shareholders Schedule Of Fair-value Of 933,000 Warrants Using The Following Assumptions 1	128.26%
Loans Payable Shareholders Schedule Of Fair-value Of 933,000 Warrants Using The Following Assumptions 2	0.001
Loans Payable Shareholders Schedule Of Fair-value Of 933,000 Warrants Using The Following Assumptions 3	0.33
Loans Payable Shareholders Schedule Of Fair-value Of 933,000 Warrants Using The Following Assumptions 4	5
Loans Payable Shareholders Schedule Of Fair-value Of 933,000 Warrants Using The Following Assumptions 5	1.01%
Loans Payable Shareholders Schedule Of Fair-value Of 933,000 Warrants Using The Following Assumptions 6	$0

Schedule_of_fairvalue_of_25000

Schedule of fair-value of 25,000 warrants using the following assumptions (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
	Y
Loans Payable Shareholders Schedule Of Fair-value Of 25,000 Warrants Using The Following Assumptions 1	399.77%
Loans Payable Shareholders Schedule Of Fair-value Of 25,000 Warrants Using The Following Assumptions 2	0.01
Loans Payable Shareholders Schedule Of Fair-value Of 25,000 Warrants Using The Following Assumptions 3	0.4
Loans Payable Shareholders Schedule Of Fair-value Of 25,000 Warrants Using The Following Assumptions 4	2
Loans Payable Shareholders Schedule Of Fair-value Of 25,000 Warrants Using The Following Assumptions 5	0.27%
Loans Payable Shareholders Schedule Of Fair-value Of 25,000 Warrants Using The Following Assumptions 6	$0

Schedule_of_Warrants_Valuation

Schedule of Warrants Valuation Assumptions (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
	Y
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 1	118.89%
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 2	128.26%
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 3	0.001
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 4	$1
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 5	0.27
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 6	0.45
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 7	2
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 8	5
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 9	0.27%
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 10	1.01%
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 10	$160

Schedule_of_Warrants_Valuation1

Schedule of Warrants Valuation assumptions resulted in a fair value of $241,697 (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
	Y
Stockholders Deficit Schedule Of Warrants Valuation Assumptions Resulted In A Fair Value Of $241,697 1	128.26%
Stockholders Deficit Schedule Of Warrants Valuation Assumptions Resulted In A Fair Value Of $241,697 2	152.79%
Stockholders Deficit Schedule Of Warrants Valuation Assumptions Resulted In A Fair Value Of $241,697 3	0.39
Stockholders Deficit Schedule Of Warrants Valuation Assumptions Resulted In A Fair Value Of $241,697 4	$0.50
Stockholders Deficit Schedule Of Warrants Valuation Assumptions Resulted In A Fair Value Of $241,697 5	0.39
Stockholders Deficit Schedule Of Warrants Valuation Assumptions Resulted In A Fair Value Of $241,697 6	0.67
Stockholders Deficit Schedule Of Warrants Valuation Assumptions Resulted In A Fair Value Of $241,697 7	4.67
Stockholders Deficit Schedule Of Warrants Valuation Assumptions Resulted In A Fair Value Of $241,697 8	0.15%
Stockholders Deficit Schedule Of Warrants Valuation Assumptions Resulted In A Fair Value Of $241,697 9	0.41%
Stockholders Deficit Schedule Of Warrants Valuation Assumptions Resulted In A Fair Value Of $241,697 10	$0

Schedule_of_Fair_Value_Assumpt

Schedule of Fair Value Assumptions used for Warrants Issued for Services (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
	Y
Stockholders Deficit Schedule Of Fair Value Assumptions Used For Warrants Issued For Services 1	118.56%
Stockholders Deficit Schedule Of Fair Value Assumptions Used For Warrants Issued For Services 2	128.26%
Stockholders Deficit Schedule Of Fair Value Assumptions Used For Warrants Issued For Services 3	0.001
Stockholders Deficit Schedule Of Fair Value Assumptions Used For Warrants Issued For Services 4	$0.75
Stockholders Deficit Schedule Of Fair Value Assumptions Used For Warrants Issued For Services 5	0.39
Stockholders Deficit Schedule Of Fair Value Assumptions Used For Warrants Issued For Services 6	0.42
Stockholders Deficit Schedule Of Fair Value Assumptions Used For Warrants Issued For Services 7	5
Stockholders Deficit Schedule Of Fair Value Assumptions Used For Warrants Issued For Services 8	1.39%
Stockholders Deficit Schedule Of Fair Value Assumptions Used For Warrants Issued For Services 9	1.54%
Stockholders Deficit Schedule Of Fair Value Assumptions Used For Warrants Issued For Services 10	$0

Schedule_of_Warrants_Activity_

Schedule of Warrants Activity (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Stockholders Deficit Schedule Of Warrants Activity 1	$2,318,928
Stockholders Deficit Schedule Of Warrants Activity 2	0.29
Stockholders Deficit Schedule Of Warrants Activity 3	25,000
Stockholders Deficit Schedule Of Warrants Activity 4	0.01
Stockholders Deficit Schedule Of Warrants Activity 5	450,000
Stockholders Deficit Schedule Of Warrants Activity 6	0.001
Stockholders Deficit Schedule Of Warrants Activity 7	420,000
Stockholders Deficit Schedule Of Warrants Activity 8	0.001
Stockholders Deficit Schedule Of Warrants Activity 9	110,000
Stockholders Deficit Schedule Of Warrants Activity 10	1
Stockholders Deficit Schedule Of Warrants Activity 11	480,000
Stockholders Deficit Schedule Of Warrants Activity 12	0.001
Stockholders Deficit Schedule Of Warrants Activity 13	1,683,000
Stockholders Deficit Schedule Of Warrants Activity 14	0.001
Stockholders Deficit Schedule Of Warrants Activity 15	200,000
Stockholders Deficit Schedule Of Warrants Activity 16	0.2
Stockholders Deficit Schedule Of Warrants Activity 17	230,000
Stockholders Deficit Schedule Of Warrants Activity 18	0.65
Stockholders Deficit Schedule Of Warrants Activity 19	400,000
Stockholders Deficit Schedule Of Warrants Activity 20	0.001
Stockholders Deficit Schedule Of Warrants Activity 21	-70,000
Stockholders Deficit Schedule Of Warrants Activity 22	0.001
Stockholders Deficit Schedule Of Warrants Activity 23	-140,000
Stockholders Deficit Schedule Of Warrants Activity 24	1.48
Stockholders Deficit Schedule Of Warrants Activity 25	$6,106,928
Stockholders Deficit Schedule Of Warrants Activity 26	0.12